AI Drug Discovery Platforms 2023

AI Drug Discovery Platforms 2023

Written by Watchdoq Newsportal. September 12, 2023

In the latest wave of funding for groundbreaking health innovations, several companies have secured substantial investments to further their endeavors. These developments represent a significant stride towards advancing healthcare technologies and services.

Genesis Therapeutics (Burlingame, CA) - $200 Million
Genesis Therapeutics, a pioneer in AI technology specializing in developing medicines for patients with severe diseases, has successfully raised $200 million in funding. This funding round was co-led by renowned venture capital firm Andreessen Horowitz and an undisclosed investor. Notable participants include Fidelity Management & Research Company, BlackRock, NVentures, T. Rowe Price Associates, Rock Springs Capital, Radical Ventures, and Menlo Ventures. Genesis Therapeutics continues to make significant strides in leveraging AI to revolutionize disease management.

VBA (Milwaukee, WI) - $156 Million
Milwaukee-based VBA, a leading provider of cloud-based benefits software tailored for healthcare payers, secured $156 million in funding. Spectrum Equity took the lead in this investment round, with participation from Arthur Ventures. VBA aims to enhance the efficiency and effectiveness of healthcare payer services through innovative cloud-based solutions.

Viome Life Sciences (Bellevue, WA) - $86.5 Million
Viome Life Sciences, headquartered in Bellevue, WA, specializes in longevity and preventative healthcare solutions. The company recently raised $86.5 million in funding, with investments from Khosla Ventures, Bold Capital, WRG Ventures, and others. Viome is at the forefront of advancing personalized healthcare strategies to promote longevity and well-being.

Thyme Care (Nashville, TN) - $60 Million
Thyme Care, a value-based cancer care partner headquartered in Nashville, TN, raised $60 million in funding. This funding round was co-led by Town Hall Ventures and Foresite Capital, with contributions from prominent investors, including Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital, and Frist Cressey Ventures. Thyme Care is dedicated to transforming cancer care through value-based approaches.

Mendaera (San Mateo, CA) - $24 Million
San Mateo-based Mendaera is a leading company specializing in healthcare robotics. The company secured $24 million in funding, with Lux Capital taking the lead and participation from Founders Fund, Operator Partners, Allen & Company, among others. Mendaera continues to drive innovations in the field of healthcare robotics. (London, UK) - $20 Million, based in London, UK, focuses on the secure, private, and auditable monetization of genomic data. The company recently raised $20 million from GEM Digital Limited. plays a pivotal role in ensuring the responsible utilization of genomic data.

Lindus Health (London, UK) - $18 Million
London-based Lindus Health is a dynamic clinical trials startup that secured $18 million in funding. Creandum led this investment round, with participation from notable figures like Peter Thiel, Seedcamp, Hambro Perks, and Amino Collective. Lindus Health is committed to advancing clinical trials for medical research.

Qualifyze (Frankfurt, Germany) - $12 Million
Qualifyze, headquartered in Frankfurt, Germany, offers compliance solutions tailored for the pharmaceutical industry. The company raised $12 million in funding, with contributions from HV Capital, Rheingau Founders, HarbourVest Partners, and H14. Qualifyze is poised to drive compliance excellence in pharmaceuticals.

Visana Health (Minneapolis, MN) - $10.1 Million
Visana Health, a Minneapolis-based virtual-first comprehensive women's health clinic, successfully raised $10.1 million in funding. This funding round was co-led by Flare Capital Partners and Frist Cressey Ventures, with participation from InHealth Ventures, Oxeon Partners, Pixel Perfect Ventures, Venture Investors, and others. Visana Health is dedicated to providing accessible and comprehensive healthcare for women.

Venteur (Berkeley, CA) - $7.6 Million
Berkeley-based Venteur offers a unique service that helps employees find personalized healthcare plans. The company secured $7.6 million in funding, with GSR leading the investment round. Additional participants include Headwater VC, Revelry Venture Partners, Houghton Street Ventures, Plug and Play, Techstars, CRCM Ventures, and several individual angel investors. Venteur simplifies the complex task of selecting healthcare plans.

These significant funding rounds mark exciting progress in the field of health innovation, demonstrating the commitment of these companies to advancing healthcare technologies, services, and solutions. The future of healthcare holds promising opportunities as these organizations continue to push boundaries and drive innovation.